Robert Frederich

6PUBLICATIONS
25CO-AUTHORS
PharmacogenomicsNutritional epidemiologyFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 29, 2026
Assessment of the Drug-Drug Interaction Potential of Lotiglipron (PF-07081532) with Midazolam, Omeprazole, Dabigatran, Rosuvastatin, and the Oral Contraceptives Levonorgestrel and Ethinyl Estradiol.

|Feb 09, 2026
Post-authorization safety study to assess the risk of diabetic ketoacidosis among type 2 diabetes mellitus patients treated with ertugliflozin compared to patients treated with other antihyperglycaemic agents in a Medicare and Medicaid population.

Ashish Rai, James Marshall, Sampada Nandyala

|Dec 19, 2024
Long-term weight loss and cardiorenal outcomes by baseline BMI in the VERTIS CV trial.

Francesco Cosentino, Samuel Dagogo-Jack, Robert Frederich

|Feb 10, 2023
Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity.

Linong Ji, Jie Liu, Zhi Jin Xu

Pageof 1

Frequent Collaborators

4 joint publications

Nilo B Cater

3 joint publications

Francesco Cosentino

3 joint publications

Christopher P Cannon

3 joint publications

David Z I Cherney